TY - JOUR
T1 - Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents
AU - Dong, Yizhou
AU - Shi, Qian
AU - Nakagawa-Goto, Kyoko
AU - Wu, Pei Chi
AU - Morris-Natschke, Susan L.
AU - Brossi, Arnold
AU - Bastow, Kenneth F.
AU - Lang, Jing Yu
AU - Hung, Mien Chie
AU - Lee, Kuo Hsiung
PY - 2010/1/15
Y1 - 2010/1/15
N2 - 6-Phenyl-4H-furo[3,2-c]pyran-4-one derivatives based on neo-tashinlactone (1) were synthesized and evaluated as novel anti-breast cancer agents. Compounds 10-13, 23, 25, and 27 showed potent inhibition against the SK-BR-3 breast cancer cell line. Importantly, 25 and 27 showed the highest cancer cell line selectivity, being approximately 100-250-fold more potent against SK-BR-3 (ED50 0.28 and 0.44 μM, respectively) compared with other cancer cell lines tested. In addition, 25 displayed low cytotoxicity against normal breast cell lines 184A1 and MCF10A. Compounds 25 and 27 merit further investigation in our continuing program to generate and develop selective anti-breast cancer agents.
AB - 6-Phenyl-4H-furo[3,2-c]pyran-4-one derivatives based on neo-tashinlactone (1) were synthesized and evaluated as novel anti-breast cancer agents. Compounds 10-13, 23, 25, and 27 showed potent inhibition against the SK-BR-3 breast cancer cell line. Importantly, 25 and 27 showed the highest cancer cell line selectivity, being approximately 100-250-fold more potent against SK-BR-3 (ED50 0.28 and 0.44 μM, respectively) compared with other cancer cell lines tested. In addition, 25 displayed low cytotoxicity against normal breast cell lines 184A1 and MCF10A. Compounds 25 and 27 merit further investigation in our continuing program to generate and develop selective anti-breast cancer agents.
KW - 6-Phenyl-4H-furo[3,2-c]pyran-4-ones
KW - Breast cancer
KW - Neo-tanshinlactone
UR - https://www.scopus.com/pages/publications/76449107595
U2 - 10.1016/j.bmc.2009.11.049
DO - 10.1016/j.bmc.2009.11.049
M3 - Article
C2 - 20034799
AN - SCOPUS:76449107595
SN - 0968-0896
VL - 18
SP - 803
EP - 808
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 2
ER -